Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Joint grant awarded for prostate cancer drug research

Dec. 7, 2012

Strategies to overcome drug resistance in mutation-dependent cancers

Dec. 7, 2012

The development of a murine model to investigate common pediatric soft tissue sarcomas

Dec. 5, 2012

Sunshine Biopharma completes studies of anticancer compound Adva-27a

Dec. 5, 2012

EZN-2208, a pegylated drug conjugate for brain tumors

Dec. 5, 2012

Neuren Pharmaceuticals presents novel monoclonal antibodies for cancer

Dec. 5, 2012

AVEO Oncology and Astellas begin enrollment in tivozanib/paclitaxel combination trial

Dec. 5, 2012

Results of the clinical evaluation of combination therapy for drug resistant melanoma

Dec. 5, 2012

PharmaEssentia acquires certain rights to KX-01 in Asia

Dec. 4, 2012

Cellceutix updates on Kevetrin trial

Dec. 4, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...